Vivitide Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
72
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
- Investments
-
2
Vivitide General Information
Description
Manufacturer of peptides and polyclonal antibodies intended for drug, vaccine and diagnostic development organizations. The company offers peptide arrays, catalog peptides, novel amino acids, amino acid derivatives, small molecule organic synthesis and resins for the treatment of cancer, diabetes, obesity, infection and Human Immunodeficiency Virus (HIV), providing quality and customized products.
Contact Information
Website
www.vivitide.comCorporate Office
- 65 Zub Lane
- Gardner, MA 01440
- United States
Corporate Office
- 65 Zub Lane
- Gardner, MA 01440
- United States
Vivitide Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Vivitide Comparisons
Industry
Financing
Details
Vivitide Competitors (2)
One of Vivitide’s 2 competitors is AAPPTec, a Private Equity-Backed company based in Louisville, KY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AAPPTec | Private Equity-Backed | Louisville, KY | ||||
| CPC Scientific | Formerly VC-backed | Rocklin, CA |
Vivitide Patents
Vivitide Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2688904-A1 | Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy | Active | 21-Mar-2011 | ||
| EP-2688904-A4 | Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy | Active | 21-Mar-2011 | ||
| EP-2688904-B1 | Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy | Active | 21-Mar-2011 | ||
| US-20130243802-A1 | Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy | Active | 21-Mar-2011 | ||
| US-8956878-B2 | Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy | Active | 21-Mar-2011 | C07K14/435 |
Vivitide Signals
Vivitide Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Vivitide Investments (2)
Vivitide’s most recent deal was a Buyout/LBO with Peptides International. The deal was made on 12-Dec-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Peptides International | 12-Dec-2019 | Buyout/LBO | Other Pharmaceuticals and Biotechnology | ||
| Sigma-Genosys | 01-Jan-2008 | Buyout/LBO | Discovery Tools (Healthcare) |
Vivitide FAQs
-
When was Vivitide founded?
Vivitide was founded in 1998.
-
Where is Vivitide headquartered?
Vivitide is headquartered in Gardner, MA.
-
What is the size of Vivitide?
Vivitide has 72 total employees.
-
What industry is Vivitide in?
Vivitide’s primary industry is Discovery Tools (Healthcare).
-
Is Vivitide a private or public company?
Vivitide is a Private company.
-
What is Vivitide’s current revenue?
The current revenue for Vivitide is .
-
Who are Vivitide’s investors?
Ampersand Capital Partners and Wheelock Partners have invested in Vivitide.
-
Who are Vivitide’s competitors?
AAPPTec and CPC Scientific are competitors of Vivitide.
-
When was Vivitide acquired?
Vivitide was acquired on 16-Mar-2022.
-
Who acquired Vivitide?
Vivitide was acquired by Biosynth.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process